深圳市龙岗区耳鼻咽喉医院跻身 “港澳药械通” 名单

Core Insights - The inclusion of Longgang District Ear, Nose, and Throat Hospital in the "Hong Kong-Macao Medical Device Pass" program marks a significant step in enhancing specialized medical services in the Guangdong-Hong Kong-Macao Greater Bay Area [1][2] - The "Hong Kong-Macao Medical Device Pass" initiative aims to facilitate the introduction of innovative drugs and medical devices that are urgently needed in clinical settings, benefiting local patients without the need for cross-border travel [1] Group 1 - Longgang District Ear, Nose, and Throat Hospital is now one of the seven newly designated medical institutions in Shenzhen, and the only tertiary public ENT specialty hospital in the Greater Bay Area to receive this qualification [1] - The policy has allowed the introduction of over 140 types of medical devices and drugs since its pilot launch in 2021, benefiting approximately 17,000 patients [1] - The initiative provides a platform for residents to access cutting-edge ENT, dental, and ophthalmological services locally, addressing the urgent demand for advanced medical solutions, especially for rare and complex diseases [1] Group 2 - The hospital plans to establish a comprehensive management system for the "Hong Kong-Macao Medical Device Pass," focusing on the clinical needs for medications and devices [2] - As the only ENT specialty hospital in the Greater Bay Area, it aims to develop seven specialized centers, including those for skull base surgery, sleep medicine, vestibular medicine, allergy, comfortable treatment, dental care, and ophthalmology [2] - The introduction of these medical devices will fill clinical gaps in complex hearing reconstruction, minimally invasive surgery for skull base tumors, and interventions for refractory allergic diseases, significantly enhancing the hospital's specialized treatment capabilities [2]